DOP2010000266A - Tratamiento para trastornos relacionados con los ojos - Google Patents

Tratamiento para trastornos relacionados con los ojos

Info

Publication number
DOP2010000266A
DOP2010000266A DO2010000266A DO2010000266A DOP2010000266A DO P2010000266 A DOP2010000266 A DO P2010000266A DO 2010000266 A DO2010000266 A DO 2010000266A DO 2010000266 A DO2010000266 A DO 2010000266A DO P2010000266 A DOP2010000266 A DO P2010000266A
Authority
DO
Dominican Republic
Prior art keywords
treatment
related disorders
eye related
macular degeneration
diabetic
Prior art date
Application number
DO2010000266A
Other languages
English (en)
Inventor
Thomas Oligino
Chang Hahn
Timothy A Gillespy
Ramalinga Dharanipragada
Ellen Matzkin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of DOP2010000266A publication Critical patent/DOP2010000266A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

Se describe un tratamiento para trastornos relacionados con los oios, tales como la degeneración macular, y preferentemente degeneración macular asociada a la edad, retinopatía diabética, y edema macular diabético, utilizando un compuesto de Fórmula l.
DO2010000266A 2008-03-10 2010-09-02 Tratamiento para trastornos relacionados con los ojos DOP2010000266A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3507308P 2008-03-10 2008-03-10

Publications (1)

Publication Number Publication Date
DOP2010000266A true DOP2010000266A (es) 2010-09-30

Family

ID=40583469

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2010000266A DOP2010000266A (es) 2008-03-10 2010-09-02 Tratamiento para trastornos relacionados con los ojos

Country Status (22)

Country Link
EP (1) EP2285378A1 (es)
JP (1) JP2011513488A (es)
KR (1) KR20110009084A (es)
CN (1) CN101965188A (es)
AR (1) AR070975A1 (es)
AU (1) AU2009223501A1 (es)
BR (1) BRPI0909659A2 (es)
CA (1) CA2717991A1 (es)
CL (1) CL2009000551A1 (es)
CO (1) CO6290691A2 (es)
CR (1) CR11644A (es)
DO (1) DOP2010000266A (es)
IL (1) IL207906A0 (es)
MA (1) MA32211B1 (es)
MX (1) MX2010008308A (es)
NI (1) NI201000131A (es)
NZ (1) NZ587906A (es)
RU (1) RU2010141560A (es)
SV (1) SV2010003658A (es)
TW (1) TW200950784A (es)
WO (1) WO2009114373A1 (es)
ZA (1) ZA201005337B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074776A1 (es) 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente
EP2441755A1 (en) 2010-09-30 2012-04-18 Almirall, S.A. Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2489663A1 (en) 2011-02-16 2012-08-22 Almirall, S.A. Compounds as syk kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2699568C (en) * 1999-12-24 2013-03-12 Aventis Pharma Limited Azaindoles
AU778417B2 (en) * 2000-02-25 2004-12-02 Merck & Co., Inc. Tyrosine kinase inhibitors
KR101487027B1 (ko) * 2005-09-30 2015-01-28 미카나 테라퓨틱스, 인크. 치환된 피라졸 화합물
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
CO6290691A2 (es) 2011-06-20
WO2009114373A1 (en) 2009-09-17
TW200950784A (en) 2009-12-16
EP2285378A1 (en) 2011-02-23
KR20110009084A (ko) 2011-01-27
ZA201005337B (en) 2011-04-28
MA32211B1 (fr) 2011-04-01
CN101965188A (zh) 2011-02-02
IL207906A0 (en) 2010-12-30
CA2717991A1 (en) 2009-09-17
BRPI0909659A2 (pt) 2015-09-22
NZ587906A (en) 2011-12-22
JP2011513488A (ja) 2011-04-28
RU2010141560A (ru) 2012-04-20
CR11644A (es) 2010-11-22
AR070975A1 (es) 2010-05-19
NI201000131A (es) 2011-09-29
CL2009000551A1 (es) 2009-08-21
MX2010008308A (es) 2010-08-11
SV2010003658A (es) 2011-01-31
AU2009223501A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
UY39646A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
CR20160119A (es) Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística
CO6821960A2 (es) Benzoxazepinonas fusionadas como moduladoras de canales iónicos
EA201590999A1 (ru) Пирролобензодиазепины и их конъюгаты
EA201391561A1 (ru) Новые соединения-модуляторы gpr-119
MX2015005831A (es) Antagonistas de il-6 y usos de los mismos.
GT201400131A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
PE20171444A1 (es) Compuestos antivirales
MY175318A (en) Androgen composition for treating an opthalmic condition
EA201391532A1 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
ECSP13012770A (es) Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
EA201590381A1 (ru) Замещенные пиразолы, используемые в качестве блокаторов кальциевых каналов n-типа
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
MX2013012211A (es) Derivados biciclicos substituidos de metil amina como moduladores de receptores de esfingosina-1-fosfato.
PE20151163A1 (es) Derivados de imidazopiridazina como moduladores del receptor gabaa
EA201400339A1 (ru) Новые имидазоламины в качестве модуляторов киназной активности
CR20160465A (es) Polimorfo b de la n-(2-aminofenil)-4-[n-(piridin-3-il) metoxicarbonilamino-metil] benzamida (ms-275)
CO6321281A2 (es) Derivados de tetrazol como moduladores de receptores de glutamato metabotropicos (mglurs)
CO6761304A2 (es) Nuevos compuestos de bezodioxol-piperazina
DOP2013000304A (es) Moduladores alostéricos positivos del receptor de acetilcolina nicotínico
ECSP13013016A (es) Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, y su uso como inhibidores de la cinasa del receptor vegf
DOP2010000266A (es) Tratamiento para trastornos relacionados con los ojos
GT201200328A (es) Intermedios de agomelatina y método de preparación de éstos